GENERAL16 Sept 2026
Domestic medtech manufacturers welcome Maha FDA's call for price review
Maharashtra's Food and Drug Administration (FDA) has called for a price review after Commissioner Tukaram Mundhe found mark-ups up to 2,841% on medical devices and hospital consumables. The Association of Indian Medical Device Industry (AIMED) backs this, saying it confirms its old worries about device pricing. This affects device makers, hospitals and patients. If you buy or supply such items, keep your bills and pricing papers ready.
Key Statutory Highlights
- Maharashtra FDA Commissioner Tukaram Mundhe flagged mark-ups of up to 2,841% on medical devices and hospital consumables.
- The Association of Indian Medical Device Industry (AIMED) supported the call for a price review.
- AIMED said the survey findings reinforced its long-standing concerns over the pricing framework for medical devices.
Actionable Advice for Taxpayers / Founders:If you make, sell or buy medical devices or hospital consumables, keep clear records of your purchase and sale prices and watch for any update on the Maharashtra FDA price review.
Statutory Disclaimer: TaxQue Shorts are AI-assisted editorial briefs for compliance awareness. This brief has not passed every source check; confirm the original notification before acting. This does not constitute formal legal or CA counsel.
TaxQue News Desk
Share: